Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Zhu, Chao, You, Yun-Hong, Nie, Ke-Ke, Ji, You-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595879/
https://www.ncbi.nlm.nih.gov/pubmed/31033571
http://dx.doi.org/10.1097/CM9.0000000000000196
_version_ 1783430474807377920
author Zhu, Chao
You, Yun-Hong
Nie, Ke-Ke
Ji, You-Xin
author_facet Zhu, Chao
You, Yun-Hong
Nie, Ke-Ke
Ji, You-Xin
author_sort Zhu, Chao
collection PubMed
description
format Online
Article
Text
id pubmed-6595879
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65958792019-07-02 Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer Zhu, Chao You, Yun-Hong Nie, Ke-Ke Ji, You-Xin Chin Med J (Engl) Correspondence Wolters Kluwer Health 2019-05-05 2019-05-05 /pmc/articles/PMC6595879/ /pubmed/31033571 http://dx.doi.org/10.1097/CM9.0000000000000196 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Correspondence
Zhu, Chao
You, Yun-Hong
Nie, Ke-Ke
Ji, You-Xin
Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title_full Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title_fullStr Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title_full_unstemmed Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title_short Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
title_sort icotinib plus osimertinib overcome epidermal growth factor receptor 19del/t790 m/c797s/v834l quadruplet resistance mutation in a patient with non-small cell lung cancer
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595879/
https://www.ncbi.nlm.nih.gov/pubmed/31033571
http://dx.doi.org/10.1097/CM9.0000000000000196
work_keys_str_mv AT zhuchao icotinibplusosimertinibovercomeepidermalgrowthfactorreceptor19delt790mc797sv834lquadrupletresistancemutationinapatientwithnonsmallcelllungcancer
AT youyunhong icotinibplusosimertinibovercomeepidermalgrowthfactorreceptor19delt790mc797sv834lquadrupletresistancemutationinapatientwithnonsmallcelllungcancer
AT niekeke icotinibplusosimertinibovercomeepidermalgrowthfactorreceptor19delt790mc797sv834lquadrupletresistancemutationinapatientwithnonsmallcelllungcancer
AT jiyouxin icotinibplusosimertinibovercomeepidermalgrowthfactorreceptor19delt790mc797sv834lquadrupletresistancemutationinapatientwithnonsmallcelllungcancer

Ejemplares similares